A milestone on the pathway to Lab 4.0: A new standard for the smart lab

SPECTARIS presents the first industrial communication standard for laboratory and analytical devices

28-Dec-2023 - As of December 14, 2023, the Laboratory & Analytical Device Standard (LADS) can be officially used and integrated within laboratory and analytical devices. After a four-year development phase, the first version is now available and has been guided by key use cases from industrial practice. LADS ...

Using artificial intelligence to discover therapeutic antibodies

Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics

21-Dec-2023 - Antibodies are an important tool in the human immune system’s arsenal against disease. They attach to bacteria, viruses, fungi, or toxins, marking them for destruction or removal from the body.It is this ability to recognise and mark foreign and harmful molecules and organisms that allows ...

Neuromuscular 2D model for drug research

21-Dec-2023 - In neuromuscular diseases, the interaction between neurons and muscle cells is disrupted. Researchers led by Mina Gouti are now able to simulate this in 2D in a culture dish. The approach is well suited for high-throughput screening in drug research, they write in Nature Communications. Around ...

Eppendorf and Neste forge strategic partnership to develop new line of renewable lab plastics

A sustainable choice for labs

05-Dec-2023 - Eppendorf SE Hamburg announces that it has joined forces with Neste to advance the development of lab products made with renewable raw materials. Working together, the strategic partnership made it possible to create a new line of renewable plastic lab consumables: Eppendorf Consumables BioBased. ...

Alzheimer’s Drug PRI-002 Receives EMA Approval for Phase II Trial

27-Nov-2023 - The Alzheimer’s drug candidate PRI-002 is entering the next clinical trial phase: the European Medicines Agency (EMA) has granted approval to conduct a phase II clinical trial. This is the first time that the drug candidate will be tested on a larger number of Alzheimer’s patients. The drug was ...

UK approves world's first therapy with gene scissors

Developers of the Crispr method were awarded the Nobel Prize in 2020: a drug using the gene scissors has now been approved for the first time

17-Nov-2023 - (dpa) In the UK, a drug based on the gene-scissor technology Crispr has been approved for the first time worldwide. This was announced by the Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday. The drug, called "Casgevy", has been approved for the treatment of sickle cell ...

Novel protein to prevent immune system attacks on own body

1.2 million euros for immunology start-up

24-Oct-2023 - Ulm-based company founders Dr. Arthur Dopler and Matteo Mohr receive 1.2 million euros for two years from the EXIST research transfer program. The federal and EU funding program supports start-up projects that involve a high level of risk and development effort. The funded project involves a ...

Startup HyPhoX develops miniaturized biosensors with support from BAM

"The innovative thing about our sensor is that we combine optical, electrical and biochemical analytics on one chip, and we do it in a handy, portable device"

23-Oct-2023 - Toxic substances, viruses and other microorganisms are a danger to humans and the environment. A team of founders from the Leibniz Institute for Innovative Microelectronics (IHP) and the Technical University of Wildau, with the support of the Federal Institute for Materials Research and Testing ...

Collaboration to develop vaccine against Helicobacter pylori

Core Facility Animal Models and start-up company Iguana cooperate

17-Oct-2023 - The Core Facility Animal Models (CAM) announces a new collaboration with drug discovery start-up Iguana Biotechnology GmbH (Iguana) to test their innovative vaccine candidate against Helicobacter pylori. Helicobacter pylori is one of the most common infectious diseases worldwide. It is a ...

Fraunhofer IPA transfers rights to use laboratory robot KEVIN United Robotics Group

KEVIN can be flexibly and intuitively integrated into laboratory infrastructures and automates processes

17-Oct-2023 - United Robotics Group (URG) and the Fraunhofer Institute for Manufacturing Engineering and Automation IPA have signed a licensing agreement as part of their newly concluded technological partnership. The content of the agreement is the distribution and further development of the laboratory robot ...